BLUE DIAMOND VENTU COM STK NPV (OTCMKTS:BLDV) Launches International Cannabis Project


BLUE DIAMOND VENTU COM STK NPV (OTCMKTS:BLDV) shares more than doubled recently. Now, the company announced that it entered into a joint development agreement, on what is dubbed as the “Black Friday” for the cannabis industry. More on that news later. First, let’s take a look at the company profile.


Blue Diamond Ventures Inc aims to partner with individuals and companies that share a common synergy, mission and vision to enable products and services that are produced, delivered and consumed utilizing fewer natural resources, providing a sustainable alternative to traditional products on the market today. As a diversified customer centric management and holding company, it seeks opportunities in various markets and is driven by critical thinking and the scientific method.


Let’s get into the company news now. BLUE DIAMOND VENTU COM STK NPV (OTCMKTS:BLDV) announced recently that it entered into a Joint Development Agreement with Alternative Medical Solutions in order to import and export targeted medicinal cannabis products and advanced cannabis technologies, to and from Canada.


Alternative Medical Solutions is currently in its final stage to potentially gain a full license to market, grow and sell medicinal cannabis products through Health Canada. Now, Blue Diamond Ventures and Alternative Medical Solutions has been working together over the past year in order to finalize funding for its 50K square foot cultivation facility.




According to Blue Diamond Ventures CEO Joshua B. Alper, “There has been recognition, by the Canadian Government, for the need to allow import and export in this industry.”


Alper continued, “This new effort will ensure that AMS, when licensed, will be a Global Project, with their products being available worldwide and with access to the ingredients and technology that will continue to make AMS a leader in the Canadian market.”


According to Alternative Medical Solutions VP of Business Development Joseph Groleau, “We are excited to launch this effort with BLDV…With the specialized products and technologies coming into Canada from Israel, and access to global markets with our finished products, we see this as a separate profit center that could even outgrow our efforts in cultivation.”

Blue Diamond Ventures noted that Canada would be the home of the new joint, and the first market focus would be to bring Israeli marijuana products and technology to Canada, legally.


Alper concluded, “AMS is the perfect partner for this project…They have a great team at AMS that has been challenged by the ever-shifting landscape of compliance and financial requirements, this project can create significant revenue even prior to AMS receiving the cultivation and manufacturing licenses from Health Canada.”


Now, Alper, who is fluent in Hebrew, has been the main person involved in attempting to import and exporting products from Israel, to Canada, and the U.S. for over 25 years. That said, he’ll be managing the efforts, along with a team of experts. With this amount of experience, Alper could have connections in Israel, which could potentially benefit Blue Diamond Ventures.


That in mind, with Canada planning to be one of the world leader’s in the legal cannabis market, Prime Minister Justin Trudeau recently introduced a bill to legalize the sale, growth and consumption of recreational marijuana. Now, this could be a key revenue drivers for cannabis-related companies, such as Blue Diamond Ventures.


BLDV could continue its recent extent after this development. Now, if you missed this news, you might want to consider following the stock and industry, with the ongoing changes in the Canadian cannabis industry. However, you don’t have to constantly be on the computer to do so. To stay up to date on BLDV, all you have to do is subscribe to our free newsletter, by entering your email address in the box below. Then, you’re on your way to receive developments, if any, in BLDV.


Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in BLDV stock, short or long.